These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 926982)

  • 1. [Results of two double-blind studies on the effect of silymarine in chronic hepatitis (author's transl)].
    Kiesewetter E; Leodolter I; Thaler H
    Leber Magen Darm; 1977 Oct; 7(5):318-23. PubMed ID: 926982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical experience with silymarin in the treatment of chronic liver disease(author's transl)].
    Reutter FW; Haase W
    Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1145-51. PubMed ID: 1099576
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres (author's transl)].
    Magliulo E; Gagliardi B; Fiori GP
    Med Klin; 1978 Jul; 73(28-29):1060-5. PubMed ID: 353464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the Romanian product Silimarina in the treatment of chronic liver diseases.
    Tănăsescu C; Petrea S; Băldescu R; Macarie E; Chiriloiu C; Purice S
    Med Interne; 1988; 26(4):311-22. PubMed ID: 3072661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
    Fehér J; Deák G; Müzes G; Láng I; Niederland V; Nékám K; Kárteszi M
    Orv Hetil; 1989 Dec; 130(51):2723-7. PubMed ID: 2574842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of (+)-cyanidanol-3 on acute hepatitis. Results of a double blind study (author's transl)].
    Rehmann I; Heinkel K
    Med Klin; 1977 Dec; 72(50):2159-64. PubMed ID: 339045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients].
    Trinchet JC; Coste T; Lévy VG; Vivet F; Duchatelle V; Legendre C; Gotheil C; Beaugrand M
    Gastroenterol Clin Biol; 1989; 13(2):120-4. PubMed ID: 2707520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis (author's transl)].
    Benda L; Dittrich H; Ferenzi P; Frank H; Wewalka F
    Wien Klin Wochenschr; 1980 Oct; 92(19):678-83. PubMed ID: 7008367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S; Gonvers JJ; Hofstetter JR
    Schweiz Rundsch Med Prax; 1975 May; 64(19):595-8. PubMed ID: 51497
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
    Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J
    Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of a certain type of 2 x 3 tables, exemplified by biopsy findings in a controlled clinical trial.
    Scheiber V; Wohlzogen FX
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):533-5. PubMed ID: 365798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of carsil and legalon in treating chronic liver diseases].
    Brailski Kh; Chernev K; Etŭrska M; Donov M; Velev G
    Vutr Boles; 1986; 25(3):43-9. PubMed ID: 3765578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sylimarine in the treatment of chronic hepatitis].
    Sawaryn T; Szymoński K; Machalska M
    Przegl Epidemiol; 1977; 31(4):445-50. PubMed ID: 607279
    [No Abstract]   [Full Text] [Related]  

  • 14. [Isoprinosine therapy in chronic hepatitis C (multicenter placebo-controlled double-blind prospective study)].
    Pár A; Beró T; Brasch G; Gógl A; Kamarás G; Méhesfalvi E; Ozsvár Z; Paál M; Szipöcs I; Telegdy L
    Orv Hetil; 1993 May; 134(19):1015-9. PubMed ID: 7684118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
    Gharagozloo M; Moayedi B; Zakerinia M; Hamidi M; Karimi M; Maracy M; Amirghofran Z
    Fundam Clin Pharmacol; 2009 Jun; 23(3):359-65. PubMed ID: 19453758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levamisole therapy in chronic hepatitis--results of a multicentric double blind trial.
    Nilius R; Schentke U; Otto L; Teichmann W; Zipprich B; Schmidt W; Brügmann E; Busse HJ
    Hepatogastroenterology; 1983 Jun; 30(3):90-2. PubMed ID: 6350136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
    Cadranel JF; Di Martino V; Dorent R; Bernard B; Hoang C; Myara A; Pauwels A; Ghoussoub JJ; Perrin M; Grippon P; Thabut D; Trivin F; Huraux JM; Gandjbakhch I; Opolon P; Lunel F
    Transplantation; 2003 Apr; 75(7):977-82. PubMed ID: 12698083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Controlled study of the effect of silymarin on alcoholic liver disease].
    Bunout D; Hirsch S; Petermann M; de la Maza MP; Silva G; Kelly M; Ugarte G; Iturriaga H
    Rev Med Chil; 1992 Dec; 120(12):1370-5. PubMed ID: 1343377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of chronic hepatitis (author's transl)].
    Siede W
    Dtsch Z Verdau Stoffwechselkr; 1979; 39(2):57-69. PubMed ID: 378653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)].
    Müzes G; Deák G; Láng I; Nékám K; Niederland V; Fehér J
    Orv Hetil; 1990 Apr; 131(16):863-6. PubMed ID: 2345633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.